Histopathology of carotid atherosclerotic disease

Neurosurgery

Volumn 59, Issue 5 SUPPL., 2006, Pages

  Virmani, Renu ^a   Ladich, Elena R ^a,b   Burke, Allen P ^a   Kolodgie, Frank D ^a  

^a International Registry of Pathology   (United States)

^b NONE   (United States)

Author keywords

Atherosclerotic carotid disease; Cerebral ischemic syndromes; Stroke

Indexed keywords

ANTILIPEMIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE CORONARY SYNDROME; AORTA ARCH; AORTA ATHEROSCLEROSIS; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; BRAIN ATHEROSCLEROSIS; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CAROTID ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CORONARY ARTERY ATHEROSCLEROSIS; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DISEASE SEVERITY; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; RISK FACTOR; RISK REDUCTION; STROKE; TREATMENT OUTCOME;

EID: 33750308001     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000239895.00373.E4     Document Type: Review

References (38)

1. Amarenco P, Cohen A, Tzourio C, Bertrand B, Hommel M, Besson G, Chauvel C, Touboul PJ, Bousser MG: Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med 331:1474-1479, 1994.
2. Barnett HJ, Meldrum HE, Eliasziw M, North American Symptomatic Carotid Endarterectomy Trial (NASCET) collaborators: The appropriate use of carotid endarterectomy. CMAJ 166:1169-1179, 2002.
3. Barnett HJ, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB, Rankin RN, Clagett GP, Hachinski VC, Sackett DL, Thorpe KE, Meldrum HE, Spence JD: Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 339:1415-1425, 1998.
4. Bassiouny HS, Davis H, Massawa N, Gewertz BL, Glagov S, Zarins CK: Critical carotid stenoses: Morphologic and chemical similarity between symptomatic and asymptomatic plaques. J Vasc Surg 9:202-212, 1989.
5. Bassiouny HS, Sakaguchi Y, Mikucki SA, McKinsey JF, Piano G, Gewertz BL, Glagov S: Juxtalumenal location of plaque necrosis and neoformation in symptomatic carotid stenosis. J Vasc Surg 26:585-594, 1997.
6. Bostom AG, Rosenberg IH, Silbershatz H, Jacques PF, Selhub J, D'Agostino RB, Wilson PW, Wolf PA: Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: The Framingham Study. Ann Intern Med 131:352-355, 1999.
7. Burke AP, Farb A, Malcom GT, Liang Y, Smialek JE, Virmani R: Plaque rupture and sudden death related to exertion in men with coronary artery disease. JAMA 281:921-926, 1999.
8. Burke AP, Kolodgie FD, Farb A, Weber DK, Malcom GT, Smialek J, Virmani R: Healed plaque ruptures and sudden coronary death: Evidence that subclinical rupture has a role in plaque progression. Circulation 103:934-940, 2001.
9. Carr S, Farb A, Pearce WH, Virmani R, Yao JS: Atherosclerotic plaque rupture in symptomatic carotid artery stenosis. J Vasc Surg 23:755-765, 1996.
10. Clagett GP, Robinowitz M, Youkey JR, Fisher DF, Fry RE, Myers SI, Lee EL, Collins GJ Jr, Virmani R: Morphogenesis and clinicopathologic characteristics of recurrent carotid disease. J Vasc Surg 3:10-23, 1986.
11. Das SK, Brow TD, Pepper J: Continuing controversy in the management of concomitant coronary and carotid disease: An overview. Int J Cardiol 74:47-65, 2000.
12. Davila-Roman VG, Barzilai B, Wareing TH, Murphy SF, Schechtman KB, Kouchoukos NT: Atherosclerosis of the ascending aorta. Prevalence and role as an independent predictor of cerebrovascular events in cardiac patients. Stroke 25:2010-2016, 1994.
13. Ecker RD, Pichelmann MA, Meissner I, Meyer FB: Durability of carotid endarterectomy. Stroke 34:2941-2944, 2003.
14. Executive Committee for Asymptomatic Carotid Artery Arthrosclerosis Study: Endarterectomy for asymptomatic carotid artery stenosis. JAMA 273:1421-1428, 1995.
15. Frijns CJ, Kappelle LJ: Inflammatory cell adhesion molecules in ischemic cerebrovascular disease. Stroke 33:2115-2122, 2002.
16. Glagov S, Zarins C, Giddens DP, Ku DN: Hemodynamics and atherosclerosis. Insights and perspectives gained from studies of human arteries. Arch Pathol Lab Med 112:1018-1031, 1988.
17. Goldstein LB, Adams R, Becker K, Furberg CD, Gorelick PB, Hademenos G, Hill M, Howard G, Howard VJ, Jacobs B, Levine SR, Mosca L, Sacco RL, Sherman DG, Wolf PA, del Zoppo GJ: Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation 103:163-182, 2001.
18. Golledge J, Greenhalgh RM, Davies AH: The symptomatic carotid plaque. Stroke 31:774-781, 2000.
19. Hunter GC: Edgar J. Poth Memorial/W.L. Gore and Associates, Inc. Lectureship. The clinical and pathological spectrum of recurrent carotid stenosis. Am J Surg 174:583-588, 1997.
20. Kolodgie FD, Gold HK, Burke AP, Fowler DR, Kruth HS, Weber DK, Farb A, Guerrero LJ, Hayase M, Kutys R, Narula J, Finn AV, Virmani R: Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 349:2316-2325, 2003.
21. Mauriello A, Sangiorgi G, Palmieri G, Virmani R, Holmes DR Jr, Schwartz RS, Pistolese R, Ippoliti A, Spagnoli LG: Hyperfibrinogenemia is associated with specific histocytological composition and complications of atherosclerotic carotid plaques in patients affected by transient ischemic attacks. Circulation 101:744-750, 2000.
22. Mofidi R, Crotty TB, McCarthy P, Sheehan SJ, Mehigan D, Keaveny TV: Association between plaque instability, angiogenesis and symptomatic carotid occlusive disease. Br J Surg 88:945-950, 2001.
23. North American Symptomatic Carotid Endarterectomy Trial Collaborators: Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 325:445-453, 1991.
24. Pauletto P, Puato M, Faggin E, Santipolo N, Pagliara V, Zoleo M, Deriu GP, Grego F, Plebani M, Sartore S, Bon GB, Heymes C, Samuel JL, Pessina AC: Specific cellular features of atheroma associated with development of neointima after carotid endarterectomy: The carotid atherosclerosis and restenosis study. Circulation 102:771-778, 2000.
25. Redgrave JN, Lovett JK, Gallagher PJ, Rothwell PM: Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: The Oxford plaque study. Circulation 113:2320-2328, 2006.
26. Rost NS, Wolf PA, Kase CS, Kelly-Hayes M, Silbershatz H, Massaro JM, D'Agostino RB, Franzblau C, Wilson PW: Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: The Framingham study. Stroke 32:2575-2579, 2001.
27. Spagnoli LG, Mauriello A, Palmieri G, Santeusanio G, Amante A, Taurino M: Relationships between risk factors and morphological patterns of human carotid atherosclerotic plaques. A multivariate discriminant analysis. Atherosclerosis 108:39-60, 1994.
28. Spagnoli LG, Mauriello A, Sangiorgi G, Fratoni S, Bonanno E, Schwartz RS, Piepgras DG, Pistolese R, Ippoliti A, Holmes DR Jr: Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke. JAMA 292:1845-1852, 2004.
29. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W, Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW: A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 92:1355-1374, 1995.
30. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W Jr, Rosenfeld ME, Schaffer SA, Schwartz CJ, Wagner WD, Wissler RW: A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 89:2462-2478, 1994.
31. Takaya N, Yuan C, Chu B, Saam T, Polissar NL, Jarvik GP, Isaac C, McDonough J, Natiello C, Small R, Ferguson MS, Hatsukami TS: Presence of intraplaque hemorrhage stimulates progression of carotid atherosclerotic plaques: A high-resolution magnetic resonance imaging study. Circulation 111:2768-2775, 2005.
32. The French Study of Aortic Plaques in Stroke Group: Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. N Engl J Med 334:1216-1221, 1996.
33. Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, Zheng ZJ, Flegal K, O'Donnell C, Kittner S, Lloyd-Jones D, Goff DC Jr, Hong Y, Adams R, Friday G, Furie K, Gorelick P, Kissela B, Marler J, Meigs J, Roger V, Sidney S, Sorlie P, Steinberger J, Wasserthiel-Smoller S, Wilson M, Wolf P: Heart disease and stroke statistics-2006 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 113:e85-e151, 2006.
34. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM: Lessons from sudden coronary death: A comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 20:1262-1275, 2000.
35. White HD, Simes RJ, Anderson NE, Hankey GJ, Watson JD, Hunt D, Colquhoun DM, Glasziou P, MacMahon S, Kirby AC, West MJ, Tonkin AM: Pravastatin therapy and the risk of stroke. N Engl J Med 343:317-326, 2000.
36. Wolf PA: Prevention of stroke. Lancet 352 [Suppl 3]:SIII15-SIII18, 1998.
37. Wolf PA, Grotta JC: Cerebrovascular disease. Circulation 102 [Suppl 4]:IV75-IV80, 2000.
38. Zhao XQ, Yuan C, Hatsukami TS, Frechette EH, Kang XJ, Maravilla KR, Brown BG: Effects of prolonged intensive lipid-lowering therapy on the characteristics of carotid atherosclerotic plaques in vivo by MRI: A case-control study. Arterioscler Thromb Vasc Biol 21:1623-1629, 2001.